Rimegepant for the treatment of Acute Migraine
Rimegepant potentially offers an alternative to current agents, particularly for patients who have contraindications to the use of triptans. This includes patients with underlying cardiovascular diseases, or who either do not respond or have inadequate or inconsistent response to triptans or are intolerant to them.
Neridronic Acid (Nerixia) for Complex Regional Pain Syndrome
Currently there are no approved treatments for CRPS. Neridronic acid administered by injection is currently being developed to treat CRPS and early results indicate that it has the possibility to control the condition. If approved neridronic acid will be a potential new treatment for CRPS.
Mirogabalin for pain due to fibromyalgia
Mirogabalin is a new drug to treat pain associated with fibromyalgia. Fibromyalgia is a long-term condition that causes pain all over the body. Mirogabalin is taken by mouth once a day at bedtime. If licensed, mirogabalin may offer patients with fibromyalgia an additional treatment option.
XG 102 for post-operative inflammation and pain following cataract surgery
XG 102 is a new drug injected into the eye to treat pain and inflammation in people who have had a cataract operation. A cataract occurs when the lens in the eye becomes cloudy causing blurred vision. Cataracts are very common and usually affect those over the age of 65 years. More than 300,000 cataract …
Tetrodotoxin for moderate to severe, inadequately controlled cancer-related pain
Cancer-related pain can arise from both ongoing tissue damage and treatments such as surgery or radiotherapy. Many patients use opioid-based pain killers to manage cancer-related pain but often they do not have complete pain relief. Tetrodotoxin is a new drug that blocks pain transmission. It is reported to be a well-tolerated, more potent analgesic than …
AXS 02 (zoledronic acid) for type I complex regional pain syndrome
Complex regional pain syndrome is a painful condition that can occur in an arm or leg after a broken bone, operation or other injury. The cause of this condition is not understood, and there is currently no cure for complex regional pain syndrome. AXS 02 is a new drug for complex regional pain syndrome in …
High definition transcranial direct current stimulation for the treatment of fibromyalgia pain
High definition transcranial direct current stimulation (HD-tDCS) is a device to treat the muscle pain people get with fibromyalgia, where the usual pain killing treatment has not worked. Fibromyalgia is a relatively common muscle condition, the specific cause for which is currently not known. The technology consists of electrical conductors on a cap through which …
Methoxyflurane (Penthrox) for emergency relief of moderate to severe pain
Acute pain is a type of pain that typically does not last longer than 6 months and stops when its underlying cause has been treated or has healed. It is commonly associated with broken bones, burns, pain after surgery or medical conditions such as heart attacks. Methoxyflurane is a new drug for the emergency treatment …
ivWatch Model 400 patient monitor for continuous monitoring of IV sites
The ivWatch Model 400 patient monitor helps doctors and nurses find out whether a drip in the vein is leaking into the surrounding tissue. If this happens, it can cause pain, infection, tissue damage and loss of limb. The ivWatch system contains a patient monitor, a light, and a single-use container that secures the light …
ATI™ Neurostimulation System for cluster headache
The ATI™ Neurostimulation System, developed by Autonomic Technologies Inc, is a rechargeable, implantable neuro-stimulator of the sphenopalatine ganglion, designed to relieve the acute pain of cluster headache and to reduce the frequency of cluster headache attacks.